{"id":48583,"date":"2022-09-20T15:02:04","date_gmt":"2022-09-20T13:02:04","guid":{"rendered":"https:\/\/pharma-trend.com\/en\/atrium-health-ciso-todd-greene-joins-semperis-as-strategic-advisor\/"},"modified":"2022-09-20T15:02:04","modified_gmt":"2022-09-20T13:02:04","slug":"atrium-health-ciso-todd-greene-joins-semperis-as-strategic-advisor","status":"publish","type":"post","link":"https:\/\/pharma-trend.com\/en\/atrium-health-ciso-todd-greene-joins-semperis-as-strategic-advisor\/","title":{"rendered":"Atrium Health CISO Todd Greene Joins Semperis as Strategic Advisor"},"content":{"rendered":"
\n

\nAtrium Health Recently Participated in Semperis\u2019 $200M+ Funding Round, Led by KKR<\/i>\n<\/p>\n

<\/a><\/p>\n

HOBOKEN, N.J.–(BUSINESS WIRE)–Semperis<\/a>, a pioneer of identity-driven cyber resilience for enterprises, today announced the addition of Todd Greene, Vice President & Enterprise CISO at Charlotte, North Carolina-based Atrium Health, to its Strategic Advisory Board. Atrium Health participated in Semperis’ recent Series C funding round<\/a> of more than $200 million, led by KKR. In his advisory role, Todd will guide Semperis\u2019 healthcare-specific initiatives and be a strategic resource for customers, including the world\u2019s largest health systems.\n<\/p>\n

\n\u201cJust as healthcare leaders unite to make groundbreaking discoveries for better medical outcomes, we need to take the same collaborative approach to cybersecurity research and innovation for a safer world,\u201d said Greene. \u201cAtrium Health seeks out companies building category-defining solutions that benefit the entire healthcare industry. Semperis is widely adopted in the healthcare sector, with a focus on protecting critical and persistently targeted identity systems, like Active Directory and Azure AD. It\u2019s an honor to join Semperis as a strategic advisor and provide my first-hand perspective, representing healthcare CISOs dealing with the ongoing, daily challenges of cyber threats.\u201d\n<\/p>\n

\nGreene has been with Atrium Health for more than 23 years. Over time, he has been part of the organization\u2019s growth into an integrated, multi-state health provider that now includes Atrium Health Wake Forest Baptist, also in North Carolina, and Atrium Health Navicent and Atrium Health Floyd in Georgia.\n<\/p>\n

\nIn January 2000, Greene became a founding member of the newly created Information Security department, where he has served in a variety of roles. He has also led several other major initiatives during his tenure, including Health Information Exchange and Disaster Recovery. Becker\u2019s Hospital Review recognized Greene as one of 61 \u201cCISOs To Know in 2020.\u201d\n<\/p>\n

\n\u201cThe stakes are higher in healthcare, as cyberattacks can literally put lives at risk,\u201d said Semperis CEO Mickey Bresman. \u201cCutting-edge innovation is in Atrium Health\u2019s DNA, and I admire Todd\u2019s long track record of cybersecurity leadership \u2013 especially in the areas of threat exchange and research, disaster recovery and customer advocacy.”\n<\/p>\n

\nOrganizations in the healthcare sector are among the most targeted by ransomware attackers. The exploitation of enterprise identity systems such as Microsoft Active Directory (AD) and Azure AD, used in over 90% of enterprises, is a common thread in the surge of ransomware attacks on healthcare companies. Attackers take advantage of weak AD configurations to identify attack paths, access privileged credentials and deploy ransomware. With its multi-layered defense approach before, during and after an attack, Semperis offers the industry\u2019s most comprehensive security technology for hybrid AD, combined with incident response expertise.\n<\/p>\n

\n\u201cSemperis is often called on to help hospitals regain control of their AD environments after a cyberattack so that operations can swiftly resume without disrupting patient services,\u201d continued Bresman. \u201cIn many cases, the AD is destroyed and requires our incident response experts to hunt down the adversary, close security holes and eliminate vulnerabilities so that the hospital can trust the environment again.”\n<\/p>\n

\nIn addition to scaling its staff globally, Semperis is dedicating a significant portion of its Series C funding round to research and development to drive further innovation in the Identity Threat Detection and Response (ITDR) market. Gartner recently included ITDR in its list of top cybersecurity trends for 2022<\/a>, noting that credential misuse is a primary method attackers use to access systems and achieve their goals.\n<\/p>\n

\nFor more information about Semperis\u2019 directory protection technology and expertise or to learn about open career opportunities, visit Semperis.com<\/a>.\n<\/p>\n

\nAbout Semperis
\n
<\/b>For security teams charged with defending hybrid and multi-cloud environments, Semperis ensures the integrity and availability of critical enterprise directory services at every step in the cyber kill chain and cuts recovery time by 90%. Purpose-built for securing hybrid Active Directory environments, Semperis\u2019 patented technology protects over 50 million identities from cyberattacks, data breaches and operational errors. The world\u2019s leading organizations trust Semperis to spot directory vulnerabilities, intercept cyberattacks in progress, and quickly recover from ransomware and other data integrity emergencies. Semperis is headquartered in Hoboken, New Jersey, and operates internationally, with its research and development team distributed throughout the United States, Canada and Israel.\n<\/p>\n

\nSemperis hosts the award-winning Hybrid Identity Protection conference and podcast series (www.hipconf.com<\/a>) and built the community hybrid Active Directory cyber defender tools, Purple Knight (www.purple-knight.com<\/a>) and Forest Druid. The company has received the highest level of industry accolades, recently named to Inc. Magazine\u2019s list of best workplaces for 2022 and ranked the fastest-growing cybersecurity company in America by the Financial Times. Semperis is a Microsoft Enterprise Cloud Alliance and Co-Sell partner.\n<\/p>\n

\nTwitter: https:\/\/twitter.com\/SemperisTech<\/a>
LinkedIn: https:\/\/www.linkedin.com\/company\/semperis<\/a>
Facebook: https:\/\/www.facebook.com\/SemperisTech<\/a>
YouTube: https:\/\/www.youtube.com\/channel\/UCycrWXhxOTaUQ0sidlyN9SA<\/a>\n<\/p>\n

\nAbout Atrium Health
\n
<\/b>Atrium Health<\/a> is a nationally recognized leader in shaping health outcomes through innovative research, education, and compassionate patient care. Based in Charlotte, North Carolina, Atrium Health is an integrated, nonprofit health system with more than 70,000 teammates serving patients at 40 hospitals and more than 1,400 care locations. It provides care under the Atrium Health Wake Forest Baptist<\/a> name in the Winston-Salem, North Carolina, region, as well as Atrium Health Navicent<\/a> and Atrium Health Floyd<\/a> in Georgia and Alabama. Atrium Health is renowned for its top-ranked pediatric, cancer, and heart care, as well as organ transplants, burn treatments, and specialized musculoskeletal programs. A recognized leader in experiential medical education and groundbreaking research, Wake Forest University School of Medicine<\/a> is the academic core of the enterprise, including Wake Forest Innovations<\/a>, which is advancing new medical technologies and biomedical discoveries. Atrium Health is also a leading-edge innovator in virtual care and mobile medicine, providing care close to home and in the home. Ranked nationally among U.S. News & World Report\u2019s Best Hospitals in eight pediatric specialties and for rehabilitation, Atrium Health has also received the American Hospital Association\u2019s Quest for Quality Prize and its 2021 Carolyn Boone Lewis Equity of Care Award, as well as the 2020 Centers for Medicare & Medicaid Services Health Equity Award for its efforts to reduce racial and ethnic disparities in care. With a commitment to every community it serves, Atrium Health seeks to improve health, elevate hope, and advance healing \u2013 for all, providing $2.46 billion last year in free and uncompensated care and other community benefits.\n<\/p>\n

Contacts<\/b> <\/p>\n

\nMedia:
\n
<\/b>For Semperis:
\n
Ashley Crutchfield, fama PR
\n
617-986-5025
\n
semperis@famapr.com<\/a>\n<\/p>\n<\/div>\n","protected":false},"excerpt":{"rendered":"

Atrium Health Recently Participated in Semperis\u2019 $200M+ Funding Round, Led by KKR HOBOKEN, N.J.–(BUSINESS WIRE)–Semperis, a pioneer of identity-driven cyber resilience for enterprises, today announced the addition of Todd Greene, Vice President & Enterprise CISO at Charlotte, North Carolina-based Atrium Health, to its Strategic Advisory Board. Atrium Health participated in Semperis’ recent Series C funding … [Read more…]<\/a><\/span><\/p>\n","protected":false},"author":4,"featured_media":0,"comment_status":"closed","ping_status":"closed","sticky":false,"template":"","format":"standard","meta":{"footnotes":""},"categories":[13],"tags":[],"class_list":{"0":"entry","1":"post","2":"publish","3":"author-business","4":"post-48583","6":"format-standard","7":"category-industry"},"yoast_head":"\nAtrium Health CISO Todd Greene Joins Semperis as Strategic Advisor - Pharma Trend<\/title>\n<meta name=\"robots\" content=\"index, follow, max-snippet:-1, max-image-preview:large, max-video-preview:-1\" \/>\n<link rel=\"canonical\" href=\"https:\/\/pharma-trend.com\/en\/atrium-health-ciso-todd-greene-joins-semperis-as-strategic-advisor\/\" \/>\n<meta property=\"og:locale\" content=\"en_US\" \/>\n<meta property=\"og:type\" content=\"article\" \/>\n<meta property=\"og:title\" content=\"Atrium Health CISO Todd Greene Joins Semperis as Strategic Advisor - Pharma Trend\" \/>\n<meta property=\"og:description\" content=\"Atrium Health Recently Participated in Semperis\u2019 $200M+ Funding Round, Led by KKR HOBOKEN, N.J.–(BUSINESS WIRE)–Semperis, a pioneer of identity-driven cyber resilience for enterprises, today announced the addition of Todd Greene, Vice President & Enterprise CISO at Charlotte, North Carolina-based Atrium Health, to its Strategic Advisory Board. Atrium Health participated in Semperis’ recent Series C funding ... [Read more...]\" \/>\n<meta property=\"og:url\" content=\"https:\/\/pharma-trend.com\/en\/atrium-health-ciso-todd-greene-joins-semperis-as-strategic-advisor\/\" \/>\n<meta property=\"og:site_name\" content=\"Pharma Trend\" \/>\n<meta property=\"article:published_time\" content=\"2022-09-20T13:02:04+00:00\" \/>\n<meta property=\"og:image\" content=\"https:\/\/mms.businesswire.com\/media\/20220920005227\/en\/1576189\/21\/Semperis_logo_stacked.jpg\" \/>\n<meta name=\"author\" content=\"Business Wire\" \/>\n<meta name=\"twitter:card\" content=\"summary_large_image\" \/>\n<meta name=\"twitter:label1\" content=\"Written by\" \/>\n\t<meta name=\"twitter:data1\" content=\"Business Wire\" \/>\n\t<meta name=\"twitter:label2\" content=\"Est. reading time\" \/>\n\t<meta name=\"twitter:data2\" content=\"5 minutes\" \/>\n<script type=\"application\/ld+json\" class=\"yoast-schema-graph\">{\"@context\":\"https:\\\/\\\/schema.org\",\"@graph\":[{\"@type\":\"Article\",\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/atrium-health-ciso-todd-greene-joins-semperis-as-strategic-advisor\\\/#article\",\"isPartOf\":{\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/atrium-health-ciso-todd-greene-joins-semperis-as-strategic-advisor\\\/\"},\"author\":{\"name\":\"Business Wire\",\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/#\\\/schema\\\/person\\\/02d41342c7a74fa7f0032bb35ef0bb24\"},\"headline\":\"Atrium Health CISO Todd Greene Joins Semperis as Strategic Advisor\",\"datePublished\":\"2022-09-20T13:02:04+00:00\",\"mainEntityOfPage\":{\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/atrium-health-ciso-todd-greene-joins-semperis-as-strategic-advisor\\\/\"},\"wordCount\":1074,\"publisher\":{\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/#organization\"},\"image\":{\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/atrium-health-ciso-todd-greene-joins-semperis-as-strategic-advisor\\\/#primaryimage\"},\"thumbnailUrl\":\"https:\\\/\\\/mms.businesswire.com\\\/media\\\/20220920005227\\\/en\\\/1576189\\\/21\\\/Semperis_logo_stacked.jpg\",\"articleSection\":[\"Industry\"],\"inLanguage\":\"en-US\"},{\"@type\":\"WebPage\",\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/atrium-health-ciso-todd-greene-joins-semperis-as-strategic-advisor\\\/\",\"url\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/atrium-health-ciso-todd-greene-joins-semperis-as-strategic-advisor\\\/\",\"name\":\"Atrium Health CISO Todd Greene Joins Semperis as Strategic Advisor - Pharma Trend\",\"isPartOf\":{\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/#website\"},\"primaryImageOfPage\":{\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/atrium-health-ciso-todd-greene-joins-semperis-as-strategic-advisor\\\/#primaryimage\"},\"image\":{\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/atrium-health-ciso-todd-greene-joins-semperis-as-strategic-advisor\\\/#primaryimage\"},\"thumbnailUrl\":\"https:\\\/\\\/mms.businesswire.com\\\/media\\\/20220920005227\\\/en\\\/1576189\\\/21\\\/Semperis_logo_stacked.jpg\",\"datePublished\":\"2022-09-20T13:02:04+00:00\",\"breadcrumb\":{\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/atrium-health-ciso-todd-greene-joins-semperis-as-strategic-advisor\\\/#breadcrumb\"},\"inLanguage\":\"en-US\",\"potentialAction\":[{\"@type\":\"ReadAction\",\"target\":[\"https:\\\/\\\/pharma-trend.com\\\/en\\\/atrium-health-ciso-todd-greene-joins-semperis-as-strategic-advisor\\\/\"]}]},{\"@type\":\"ImageObject\",\"inLanguage\":\"en-US\",\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/atrium-health-ciso-todd-greene-joins-semperis-as-strategic-advisor\\\/#primaryimage\",\"url\":\"https:\\\/\\\/mms.businesswire.com\\\/media\\\/20220920005227\\\/en\\\/1576189\\\/21\\\/Semperis_logo_stacked.jpg\",\"contentUrl\":\"https:\\\/\\\/mms.businesswire.com\\\/media\\\/20220920005227\\\/en\\\/1576189\\\/21\\\/Semperis_logo_stacked.jpg\"},{\"@type\":\"BreadcrumbList\",\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/atrium-health-ciso-todd-greene-joins-semperis-as-strategic-advisor\\\/#breadcrumb\",\"itemListElement\":[{\"@type\":\"ListItem\",\"position\":1,\"name\":\"Startseite\",\"item\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/\"},{\"@type\":\"ListItem\",\"position\":2,\"name\":\"Atrium Health CISO Todd Greene Joins Semperis as Strategic Advisor\"}]},{\"@type\":\"WebSite\",\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/#website\",\"url\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/\",\"name\":\"Pharma Trend\",\"description\":\"\",\"publisher\":{\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/#organization\"},\"potentialAction\":[{\"@type\":\"SearchAction\",\"target\":{\"@type\":\"EntryPoint\",\"urlTemplate\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/?s={search_term_string}\"},\"query-input\":{\"@type\":\"PropertyValueSpecification\",\"valueRequired\":true,\"valueName\":\"search_term_string\"}}],\"inLanguage\":\"en-US\"},{\"@type\":\"Organization\",\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/#organization\",\"name\":\"Pharma Trend\",\"url\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/\",\"logo\":{\"@type\":\"ImageObject\",\"inLanguage\":\"en-US\",\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/#\\\/schema\\\/logo\\\/image\\\/\",\"url\":\"\",\"contentUrl\":\"\",\"caption\":\"Pharma Trend\"},\"image\":{\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/#\\\/schema\\\/logo\\\/image\\\/\"}},{\"@type\":\"Person\",\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/#\\\/schema\\\/person\\\/02d41342c7a74fa7f0032bb35ef0bb24\",\"name\":\"Business Wire\"}]}<\/script>\n<!-- \/ Yoast SEO plugin. -->","yoast_head_json":{"title":"Atrium Health CISO Todd Greene Joins Semperis as Strategic Advisor - Pharma Trend","robots":{"index":"index","follow":"follow","max-snippet":"max-snippet:-1","max-image-preview":"max-image-preview:large","max-video-preview":"max-video-preview:-1"},"canonical":"https:\/\/pharma-trend.com\/en\/atrium-health-ciso-todd-greene-joins-semperis-as-strategic-advisor\/","og_locale":"en_US","og_type":"article","og_title":"Atrium Health CISO Todd Greene Joins Semperis as Strategic Advisor - Pharma Trend","og_description":"Atrium Health Recently Participated in Semperis\u2019 $200M+ Funding Round, Led by KKR HOBOKEN, N.J.–(BUSINESS WIRE)–Semperis, a pioneer of identity-driven cyber resilience for enterprises, today announced the addition of Todd Greene, Vice President & Enterprise CISO at Charlotte, North Carolina-based Atrium Health, to its Strategic Advisory Board. Atrium Health participated in Semperis’ recent Series C funding ... [Read more...]","og_url":"https:\/\/pharma-trend.com\/en\/atrium-health-ciso-todd-greene-joins-semperis-as-strategic-advisor\/","og_site_name":"Pharma Trend","article_published_time":"2022-09-20T13:02:04+00:00","og_image":[{"url":"https:\/\/mms.businesswire.com\/media\/20220920005227\/en\/1576189\/21\/Semperis_logo_stacked.jpg","type":"","width":"","height":""}],"author":"Business Wire","twitter_card":"summary_large_image","twitter_misc":{"Written by":"Business Wire","Est. reading time":"5 minutes"},"schema":{"@context":"https:\/\/schema.org","@graph":[{"@type":"Article","@id":"https:\/\/pharma-trend.com\/en\/atrium-health-ciso-todd-greene-joins-semperis-as-strategic-advisor\/#article","isPartOf":{"@id":"https:\/\/pharma-trend.com\/en\/atrium-health-ciso-todd-greene-joins-semperis-as-strategic-advisor\/"},"author":{"name":"Business Wire","@id":"https:\/\/pharma-trend.com\/en\/#\/schema\/person\/02d41342c7a74fa7f0032bb35ef0bb24"},"headline":"Atrium Health CISO Todd Greene Joins Semperis as Strategic Advisor","datePublished":"2022-09-20T13:02:04+00:00","mainEntityOfPage":{"@id":"https:\/\/pharma-trend.com\/en\/atrium-health-ciso-todd-greene-joins-semperis-as-strategic-advisor\/"},"wordCount":1074,"publisher":{"@id":"https:\/\/pharma-trend.com\/en\/#organization"},"image":{"@id":"https:\/\/pharma-trend.com\/en\/atrium-health-ciso-todd-greene-joins-semperis-as-strategic-advisor\/#primaryimage"},"thumbnailUrl":"https:\/\/mms.businesswire.com\/media\/20220920005227\/en\/1576189\/21\/Semperis_logo_stacked.jpg","articleSection":["Industry"],"inLanguage":"en-US"},{"@type":"WebPage","@id":"https:\/\/pharma-trend.com\/en\/atrium-health-ciso-todd-greene-joins-semperis-as-strategic-advisor\/","url":"https:\/\/pharma-trend.com\/en\/atrium-health-ciso-todd-greene-joins-semperis-as-strategic-advisor\/","name":"Atrium Health CISO Todd Greene Joins Semperis as Strategic Advisor - Pharma Trend","isPartOf":{"@id":"https:\/\/pharma-trend.com\/en\/#website"},"primaryImageOfPage":{"@id":"https:\/\/pharma-trend.com\/en\/atrium-health-ciso-todd-greene-joins-semperis-as-strategic-advisor\/#primaryimage"},"image":{"@id":"https:\/\/pharma-trend.com\/en\/atrium-health-ciso-todd-greene-joins-semperis-as-strategic-advisor\/#primaryimage"},"thumbnailUrl":"https:\/\/mms.businesswire.com\/media\/20220920005227\/en\/1576189\/21\/Semperis_logo_stacked.jpg","datePublished":"2022-09-20T13:02:04+00:00","breadcrumb":{"@id":"https:\/\/pharma-trend.com\/en\/atrium-health-ciso-todd-greene-joins-semperis-as-strategic-advisor\/#breadcrumb"},"inLanguage":"en-US","potentialAction":[{"@type":"ReadAction","target":["https:\/\/pharma-trend.com\/en\/atrium-health-ciso-todd-greene-joins-semperis-as-strategic-advisor\/"]}]},{"@type":"ImageObject","inLanguage":"en-US","@id":"https:\/\/pharma-trend.com\/en\/atrium-health-ciso-todd-greene-joins-semperis-as-strategic-advisor\/#primaryimage","url":"https:\/\/mms.businesswire.com\/media\/20220920005227\/en\/1576189\/21\/Semperis_logo_stacked.jpg","contentUrl":"https:\/\/mms.businesswire.com\/media\/20220920005227\/en\/1576189\/21\/Semperis_logo_stacked.jpg"},{"@type":"BreadcrumbList","@id":"https:\/\/pharma-trend.com\/en\/atrium-health-ciso-todd-greene-joins-semperis-as-strategic-advisor\/#breadcrumb","itemListElement":[{"@type":"ListItem","position":1,"name":"Startseite","item":"https:\/\/pharma-trend.com\/en\/"},{"@type":"ListItem","position":2,"name":"Atrium Health CISO Todd Greene Joins Semperis as Strategic Advisor"}]},{"@type":"WebSite","@id":"https:\/\/pharma-trend.com\/en\/#website","url":"https:\/\/pharma-trend.com\/en\/","name":"Pharma Trend","description":"","publisher":{"@id":"https:\/\/pharma-trend.com\/en\/#organization"},"potentialAction":[{"@type":"SearchAction","target":{"@type":"EntryPoint","urlTemplate":"https:\/\/pharma-trend.com\/en\/?s={search_term_string}"},"query-input":{"@type":"PropertyValueSpecification","valueRequired":true,"valueName":"search_term_string"}}],"inLanguage":"en-US"},{"@type":"Organization","@id":"https:\/\/pharma-trend.com\/en\/#organization","name":"Pharma Trend","url":"https:\/\/pharma-trend.com\/en\/","logo":{"@type":"ImageObject","inLanguage":"en-US","@id":"https:\/\/pharma-trend.com\/en\/#\/schema\/logo\/image\/","url":"","contentUrl":"","caption":"Pharma Trend"},"image":{"@id":"https:\/\/pharma-trend.com\/en\/#\/schema\/logo\/image\/"}},{"@type":"Person","@id":"https:\/\/pharma-trend.com\/en\/#\/schema\/person\/02d41342c7a74fa7f0032bb35ef0bb24","name":"Business Wire"}]}},"_links":{"self":[{"href":"https:\/\/pharma-trend.com\/en\/wp-json\/wp\/v2\/posts\/48583","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/pharma-trend.com\/en\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/pharma-trend.com\/en\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/pharma-trend.com\/en\/wp-json\/wp\/v2\/users\/4"}],"replies":[{"embeddable":true,"href":"https:\/\/pharma-trend.com\/en\/wp-json\/wp\/v2\/comments?post=48583"}],"version-history":[{"count":0,"href":"https:\/\/pharma-trend.com\/en\/wp-json\/wp\/v2\/posts\/48583\/revisions"}],"wp:attachment":[{"href":"https:\/\/pharma-trend.com\/en\/wp-json\/wp\/v2\/media?parent=48583"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/pharma-trend.com\/en\/wp-json\/wp\/v2\/categories?post=48583"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/pharma-trend.com\/en\/wp-json\/wp\/v2\/tags?post=48583"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}